Exhaled breath condensate as a suitable matrix to assess lung dose and effects in workers exposed to cobalt and tungsten

Environmental Health Perspectives

Volumn 112, Issue 13, 2004, Pages 1293-1298

  Goldoni, Matteo ^a   Catalani, Simona ^b   De Palma, Giuseppe ^a   Manini, Paola ^a   Acampa, Olga ^a   Corradi, Massimo ^a   Bergonzi, Roberto ^b   Apostoli, Pietro ^b   Mutti, Antonio ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Cobalt; Exhaled breath condensate; Hard metals; Lung; Malondialdehyde; Oxidative stress; Tungsten

Indexed keywords

BIOLOGICAL MARKER; COBALT; DIAMOND; MALONALDEHYDE; TUNGSTEN;

ADULT; ANALYTIC METHOD; ARTICLE; BIOLOGICAL MONITORING; BREATH ANALYSIS; CONTROLLED STUDY; COOLING; CORRELATION ANALYSIS; EXHALATION; EXPIRED AIR; FEMALE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; LUNG FUNCTION; LUNG TOXICITY; MALE; MASS SPECTROMETRY; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PRIORITY JOURNAL; URINE LEVEL; WORKSHOP;

ADULT; BREATH TESTS; CASE-CONTROL STUDIES; COBALT; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; SENSITIVITY AND SPECIFICITY; TUNGSTEN;

EID: 4644325800     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.7108     Document Type: Article

References (35)

1. ACGIH. 2003. Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH:American Conference of Governmental Industrial Hygienists.
2. Alexandersson MD. 1988, Blood and urinary concentrations as estimators of cobalt exposure. Arch Environ Health 43:299-303.
3. American Thoracic Society. 1995. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107-1113.
4. Andreoli R, Manini P, Corradi M, Mutti A, Niessen WMA. 2003. Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subject by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 17:637-645.
5. Antczak A, Gorski P. 2002. Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Mad Environ Health 15:317-323.
6. Apostoli P, Giusti D, Bartoli D, Perico A, Bavazzano P. 1998. Multiple exposure to arsecic, antimony and other elements in art glass manufacturing. Am J Ind Med 34:65-72.
7. Apostoli P, Porru S, Alessio L. 1994. Urinary cobalt excretion in short time occupational exposure to cobalt powders. Sci Total Environ 150:129-132.
8. ATSDR (Agency for Toxic Substances and Disease Registry). 1999. Cobalt. ATSDR Toxicological Profiles. Atlanta, GA:CRC Press.
9. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
10. Christensen JM, Poulsen OM. 1994. A 1982-1992 surveillance programme on Danish pottery painters. Biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes, Sci Total Environ 150:95-104.
11. Cirla AM. 1994. Cobalt-related asthma: clinical and immunological aspects. Sci Total Environ 150:85-94.
12. Corradi M, Rubinstein I, Andreoli R, Manini P, Caglieri A, Poli D, et al. 2003. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:1380-1386.
13. De Boeck M, Lombaert N, De Backer S, Finsy R, Lison D, Kirsch-Volders M. 2003. In vitro genotoxic effects of different combinations of cobalt and metallic carbide particles. Mutagenesis 18:177-186.
14. Glantz SA. 2002. Primers in Biostatistics. New York: McGraw-Hill Education.
15. IARC (International Agency for Research on Cancer). 1991. Cobalt and cobalt compounds. IARC Monogr Eval Carcinog Risks Hum 52:363-472.
16. IARC. 2003. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Cobalt in Hard-metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide (Volume 86, 7-14 October 2003). Lyon, France:International Agency for Research on Cancer. Available: http://193.51.164.11/htdocs/announcements/vol86.htm [accessed 12 July 2004].
17. Kharitonov SA, Barnes PJ. 2001. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693-1722.
18. Kraus T, Schramel P, Schaller KH, Zoebelein P, Weber A, Angerer J. 2001. Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds. Occup Environ Med 58:631-634.
19. Lasfargues G, Lison D, Maldague P, Lauwerys R. 1992. Comparative study of the acute lung toxicity of pure cobalt powder and cobalt-tungsten carbide mixture in the rat. Toxicol Appl Pharmacol 112:41-50.
20. Lauwerys R, Lison D. 1994. Health risks associated with cobalt exposure - an overview. Sci Total Environ 150:1-6.
21. Lemiere C. 2002. Non-invasive assessment of airway inflammation in occupational lung diseases. Curr Opin Allergy Clin Immunol 2:109-114.
22. Lewis CPL, Demedts M, Nemery B. 1991. Indices of oxidative stress in hamster lung following exposure to cobalt(II) ions: in vivo and in vitro studies. Am J Respir Cell Mol Biol 5:163-169.
23. Linnainmaa M, Kiilunen M. 1997. Urinary cobalt as a measure of exposure in the wet sharpening of hard metal and stellite blades. Int Arch Occup Envir Health 69:193-200.
24. Lison D. 1996. Human toxicity of cobalt-containing dust and experimental studies on the mechanism of interstitial lung disease (hard metal disease). Crit Rev Toxicol 26:585-616.
25. Lison D, Carbonnelle P, Mollo L, Lauwerys R, Fubini B. 1995. Physicochemical mechanism of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem Res Toxicol 8:600-606.
26. Lison D, De Boeck M, Verougstraete V, Kirsch-Volders M. 2001. Update on the genotoxicity and carcinogenicity of cobalt compounds. Occup Environ Med 58:619-625.
27. Mutti A, Corradi M, Apostoli P, Andreoli R, Goldoni M, Manini P, et al. 2003. Exhaled breath condensate as a tool to assess target tissue dose and effects of pneumotoxic metals [Abstract]. Am J Respir Crit Care Med 167:334.
28. Mutlu GM, Garey KW, Robbins RA, Danziger LH, Rubinstein I. 2001. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 164:731-737.
29. Nemery B, Lewis CPL, Demedts M. 1994. Cobalt and possible oxidant-mediated toxicity. Sci Total Environ 150:57-64.
30. Nordberg G. 1994. Assessment of risks in occupational cobalt exposures. Sci Total Environ 150:201-207.
31. Salnikow K, Su W, Blagosklonny MV, Costa M. 2000. Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanisms. Cancer Res 60:3375-3378.
32. Scansetti G, Lamon S, Talarico S, Botta GC, Spinelli P, Sulotto F, et al. 1985. Urinary cobalt as a measure of exposure in the hard metal industry. Int Arch Occup Environ Health 57:19-26.
33. Taylor A, Marks V. 1978. Cobalt: a review. J Hum Nutr 32:165-177.
34. Van Goethem F, Lison D, Kirsch-Volders M. 1997. Comparative evaluation of the in vitro micronucleus test and the alkaline single cell gel electrophoresis assay for the detection of DANN damaging agents: genotoxic effects of cobalt powder, tungsten carbide and cobalt-tungsten carbide. Mutat Res 392:31-43.
35. World Medical Association. 2002. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Ferney-Voltaire, France:The World Medical Association. Available: http://www.wma.net/e/policy/pdf/17c.pdf [accessed 12 July 2004].